Pages
- Corporate Governance
- Homepage
- Privacy Policy
- Site Map
- Company Directory
- Products
- Innovation, it’s in our DNA
- Company Information
- News & Updates
- Contact Us
Posts by category
- Category: Company News
- Company Update – Innovation Division Shareholder Presentation August 2023
- Exclusive Distribution of ChiroKlip®
- Allegra confirms route to FDA approval following successful pilot animal study
- Visit Allegra at the New South Wales Hand Surgery Association Annual Conference, 29 Nov – 02 Dec at Mercure Wagga Wagga
- Visit Allegra at Booth #20, AOA ASM18
- Visit Allegra at Booth #12, 2018 AOFAS Conference 17 – 19 August at Pullman Cairns International, QLD
- Revision Knee Cadaver Course
– 23 June 2018 - Meet Dr Nick Hartnell, Surgeon Advisor
- Category: Innovation & Development
- Category: Products
- Announcing the Noviomagus Cup Resector Kit
- EZ Blades gain TGA approval
- Allegra Orthopaedics – Face Shields & Face Mask Strap Holders
- Reconstruction for Acetabular Metastatic Disease
- We join in congratulating LINK®
for 40 Years of the Endo-Model® Knee, around the Globe! - Waldemar Link
- Looking for a specific device?
Products
- Alians Proximal Humerus Plating System
- Alians Elbow
- Post-surgery Rehabilitation
- Revision Surgery Instruments
- PCL Protector
- Direct Anterior Approach
- Shoulder Surgery
- Clavicle Fixation (CFS)
- CustomLINK
- HTO Activmotion S DTO
- MTP Plating System
- Footmotion Plating System
- Footmotion Screws
- Activ Fuse
- KLS Martin Capflex PIP
- EZBlades®
- KMS Saw Blades
- ChiroKlip®
- Noviomagus Cup Resector
- StripEase
- Blades Wires Pins & Screws
- Standard C Cementless Stem
- MP® Reconstruction Prosthesis
- MEGASYSTEM-C® - modular tumor and revision system
- Endo-Model® Partial Pelvis Replacement
- Combi-Cup R® Revision Cup
- CombiCup® PF® Acetabular Cup
- IP Acetabular Cup
- Ceramic Prosthesis Heads
- CoCrMo Prosthesis Heads
- St Georg SLED (Uni Knee)
- Endo-Model® Knee Fusion Nail SK
- Endo-Model® SL® Rotational and Hinge Knee
- Endo-Model® M Modular Knee
- Endo-Model® Knee
- Signature Evolve Cemented Femoral Stem
- Arthrosurface HemiCAP® Femoral Condyle
- Arthrosurface HemiCAP® PF Wave
- Arthrosurface NanoFX® Nanofracture
- Signature Logical G Series Cup
- Signature Origin Femoral Stem
- Signature Evolve Unipolar Head
- Allegra Orthopaedics ACL Screws
- Allegra K Wires and Pins
- Hintegra® Total Ankle Replacement
- Arthrosurface NanoFX® A-Curve Handle
- Arthrosurface HemiCAP®2nd MTP
- Arthrosurface HemiCAP® DF Toe
- Allegra Saw Blades
- KLS Martin RECOS® Ulna Shortening Plate
- KLS Martin Herbert Ulna Head® Prosthesis (UHP)
- KLS Martin HBS2 Compression Screw
- KLS Martin Linos Hand Fracture System
- KLS Martin IXOS® Distal Radius System
- NanoFx® Microfracture
- Arthrosurface NanoFX® (Nanofracture)
- Arthrosurface HemiCAP® Shoulder
- Medical Rotation Knee™
- Active Knee Distal First Instruments
- Total Active Knee
ASX Announcements
- 31/10/2024: AGM Extension Announcement
- 15/10/2024: Notice of Compulsory Acquisition
- 10/10/2024: Shareholders Update
- 09/10/2024: Supplementary Bidder's Statement
- 07/10/2024: Change in Substantial Holding
- 04/10/2024: Initial Director’s Interest Notice
- 04/10/2024: Final Director's Interest Notice
- 03/10/2024: Changes to Allegra Directors and Non-Executive Chairman
- 03/10/2024: Change in Substantial Holding
- 30/09/2024: Variation of Takeover Bid
- 17/09/2024: Change in Substantial Holding
- 16/09/2024: Variation of Takeover Bid
- 12/09/2024: Changes To Securities - Additional and Buy Backs
- 11/09/2024: Notification of Cessation of Securities
- 03/09/2024: Shareholders Update
- 02/09/2024: Variation of Takeover Bid
- 30/08/2024: Shareholders Update
- 30/08/2024: Change of Director's Interest Notice
- 30/08/2024: Change of Director's Interest Notice
- 15/08/2024: Change in Substantial Holding
- 13/08/2024: Change in Substantial Holding
- 12/08/2024: Shareholders Update
- 09/08/2024: Notice of Status of Conditions
- 09/08/2024: Supplementary Bidder's Statement
- 30/07/2024: Change in Substantial Holding
- 29/07/2024: Shareholder Update
- 24/07/2024: Takeover - Extension Of Offer Period
- 22/07/2024: Change in Substantial Holding
- 19/07/2024: Change in Substantial Holding
- 19/07/2024: First Supplementary Target's Statement
- 19/07/2024: Change in Substantial Holding
- 17/07/2024: Change in Substantial Holding
- 11/07/2024: Change in Substantial Holding
- 10/07/2024: Extension of Offer Period
- 10/07/2024: Notice of Condition Fulfilled
- 04/07/2024: Lodgement of Target’s Statement
- 02/07/2024: Change of Company Secretary
- 01/07/2024: Supplementary Bidder's Statement
- 01/07/2024: Notice of Change in Substantial Holding
- 26/06/2024: Change in substantial holding
- 21/06/2024: Change in Substantial Holding
- 21/06/2024: Supplementary Bidder's Statement
- 20/06/2024: Despatch of Bidder's Statement
- 19/06/2024: Change in Substantial Holding
- 19/06/2024: Bidder's Statement
- 17/06/2024: Notice of Register Date
- 27/05/2024: Company Announcement - Recommended Cash Takeover Offer
- 22/03/2024: Continuation of Suspension from Quotation
- 22/03/2024: Suspension and Half Year Financials Update
- 22/03/2024: Appendix 4D and Half Year Financial Report
- 08/03/2024: Suspension and Half Year Financials Update
- 26/02/2024: Allegra Medical Technologies Limited (ASX AMT) – Request for Voluntary Suspension
- 23/02/2024: Suspension from Official Quotation
- 21/02/2024: Confirmation of Release - AMT - Trading Halt
- 06/02/2024: Spinal Cage FDA Submission Update
- 08/12/2023: Notification of Cessation of Securities
- 05/12/2023: Spinal Cage FDA Submission Update
- 10/11/2023: Change of Director’s Interest Notice
- 10/11/2023: Notification of Cessation of Securities
- 10/11/2023: Change of Director’s Interest Notice
- 02/11/2023: Change of Company Name
- 01/11/2023: Results of 2023 Annual General Meeting
- 20/10/2023: Unlisted Options Expiring
- 12/10/2023: Confirmation of Compliance with ASX Chapter 12
- 29/09/2023: 2023 AGM - Notice of Meeting, Letter of Access and Proxy
- 28/09/2023: Spinal Cage FDA Submission Timeline Update
- 06/09/2023: Change of Director’s Interest Notice
- 06/09/2023: Notice of Change of Interests of Substantial Holder
- 06/09/2023: Change of Director’s Interest Notice
- 04/09/2023: Spinal Cage FDA Submission Update – Supplementary Announcement
- 31/08/2023: Appendix 4G and Corporate Governance Statement
- 31/08/2023: Appendix 4E and Annual Report
- 30/08/2023: Results of Pro-Rata Non-Renounceable Entitlement Offer
- 28/08/2023: Completion of Sale of the Orthopaedic Division
- 23/08/2023: Results of 2023 General Meeting
- 16/08/2023: Spinal Cage FDA Submission Update
- 25/07/2023: EGM Notice of Meeting and Proxy
- 25/07/2023: 2023 General Meeting Letter of Access and Proxy
- 19/07/2023: Proposed issue of securities
- 19/07/2023: Notice under section 708AA(2)(f) of the Corporations Act 2001 (Cth)
- 19/07/2023: Letter to Option Holder
- 19/07/2023: Letter to Ineligible Shareholders
- 19/07/2023: Pro Rata Non-Renounceable Entitlement Offer Booklet
- 19/07/2023: Rights Issue & Update on Sale of Orthopaedic Asset
- 28/06/2023: Extension of Loan Agreement with RIPL
- 03/05/2023: Company Update on Sale of Orthopaedic Asset
- 31/03/2023: AMT Submits 510(k) for Spinal Cage FDA Clearance
- 22/02/2023: Sr-HT-Gahnite Large Animal Study Results
- 02/02/2023: Company Update Correction
- 21/10/2022: 2022 AGM Letter to Shareholders and Proxy Form
- 11/08/22: Company Update
- 05/08/2022: Sr-HT-Gahnite Biological Testing
- 11/07/2022: AMT Securities Cessation Notification
- 14/03/2022: Sr-HT-Gahnite Systemic Safety Milestone
- 25/02/2022: Appendix 4D and Half Year Financial Report
- 08/02/2022: Resignation of Company Director
- 04/02/2022: Change in Company Secretary
- 31/01/2022: Sr-HT-Gahnite Large Animal Study Shows Positive Results
- 09/08/21: Improving Coating Techniques for Orthopaedic Implants
- 26/07/2021: Change of Share Registry
- 19/04/2021: Management Change - New Head of Technology and Innovation
- 06/04/2021: Sr-HT-Gahnite - Successful Pilot Animal Study
- 24 Feb 2021: Half Year Report
- 21/12/2020: Sr-HT-Gahnite - further positive results
- 03/12/2020: Sr-HT-Gahnite Project Announcement
- 25/09/2020: Annual Report 30 June 2020
- 30/08/2020: Appendix 4E and Full Year Accounts
- 07/08/20: Sr-HT-Gahnite update
- 08/07/2020: Acquisition of Patents Additional Information
- 06/07/2020: Section 708A Notification
- 06/07/2020: Appendix 2A
- 06/07/2020: Patent Acquisition for Unique Synthetic Bone Substitute
- 1/06/2020: Product Revenue - June 2020
- 15/04/2020: Face Shield Announcement
- 26/03/2020: Covid-19 Announcement
- 15/11/2019 - Spinal Cage Device Milestone: Announcement
- 30/09/2019: Security Holder Information
- 30/09/2019: Notice of 2019 AGM
- 30/09/2019: Appendix 4G & Corporate Governance Statement
- 30/08/2019: Appendix 4E & Full Year Accounts
- 21/02/2019: Appendix 4D & Half Year Report
- 21/11/2018: Bone Substitute Project - FDA Announcement
- 30/09/18: Annual Report - 30 June 2018
- 23/08/2018: Appendix 4E Financial Report 30 June 2018
- 03/08/18: IMCRC Grant Announcement
- 18/04/18: MTPConnect Grant Announcement
- 07/03/18: Non-executive Director Announcement
- 22/02/18: Half Year Financial Report – 31122017
- 14/12/17: Waldemar LINK GmbH & Co Distribution Agreement
- 30/08/17: Annual Report – 30 June 2017
- 30/08/17: Appendix 4G – Corporate Governance
- 29/08/17: Appendix 4E Annual Report – 30 June 2017
- 25/08/17: Bone Substitute Project Update
- 17/08/17: Kangaroo Tendon Collaboration Announcement
- 10/02/17: Bone Substitute Project Update
- 19/01/17: Company Secretary Resignation / Appointment
- 16/12/16: Cleansing Statement
- 16/12/16: Appendix 3B New Issue Announcement
- 30/11/16: Results of AGM
- 30/11/16: Corporate Update for AGM
- 23/11/16: Appointment of Auditor
- 31/10/16: Media Release – Bone Substitute Project Business Update
- 26/10/16: Notice of Annual General Meeting
- 26/10/16: Annual General Meeting – Proxy Form
- 26/10/16: Independent Expert’s Report
- 20/09/16: Appendix 3B New Issue Announcement
- 20/09/16: Media Release – Bone Substitute Project Update
- 30/08/16: Annual Report – 30 June 2016
- 30/08/16: Appendix 4E Annual Report – 30 June 2016
- 30/08/16: Appendix-4G Corporate Governance
- 30/08/16: Management Change
- 30/08/16: Corporate Governance Statement
- 30/08/17: Appendix 4G – Corporate Governance
- 17/08/17: Kangaroo Tendon Collaboration Announcement
- Announcement from 2016
- 30/06/16: Bone Substitute Project Loan
- 07/06/16: Bone Substitute Project Update
- 20/04/16: Update on Management Changes
- 04/02/16: Update on outsourcing of Manufacturing
- 18/11/15: Appointment of Director
- 18/11/15: Initial Director’s Interest Notice
- 04/11/15: Media Release – Outsource of Manufacturing
- 02/11/15: Final Director’s Interest Notice
- 29/10/15: Change of Management Notice
- 28/10/15: Annual General Meeting results 2015
- 29/09/2015: Change of Management Notice
- 28/09/15: Appendix 4E Preliminary Annual Report 30 June 2015
- 25/09/15: Annual General Meeting – Proxy Form
- 25/09/15: Notice of Annual General Meeting
- 25/09/15: Annual Report – 30 June 2015
- 17/03/15: Cancellation of Shares
- 25/12/15: Half Year Report to 31 December 2014
- 27/11/14: Change of Company Name
- 26/11/14: Results of AGM 2014
- 26/11/14: Final Director’s Interest Notice
- 26/11/14: Initial Director’s Interest Notice
- 26/11/14: Director Appointment/Resignation
- 20/11/14: Change In Substantial Shareholding Notice
- 19/11/14: Change in Substantial Shareholding Notice
- 19/11/14: Becoming a substantial holder
- 31/10/14: Awarded $1.6M by the NSW Medical Devices Fund
- 30/10/14: Trading Halt Request
- 30/10/14: Trading Halt
- 28/10/14: Appendix 3B
- 28/10/14 : Appendix 3B
- 24/10/14: Close of Rights Issue Offer
- 24/10/14: Notice of Annual General Meeting/Proxy Form
- 10/10/14 : Right Issue – Entitlement and Acceptance Form
- 10/10/14 : Rights Issue – Despatch of Documents to Eligible Shareholders
- 02/10/14 : Replacement Rights Prospectus
- 01/10/14 : Rights Issue – Notice to Ineligible Shareholders
- 01/10/14 : Rights Issue – Notice to Eligible Shareholders
- 29/09/14 : Non-Renounceable Pro Rata Rights Issue
- 29/09/14 : Rights Issue Prospectus
- 29/09/14 : Annual Report – 30 June 2014
- 29/09/14 : Annual Report – 30 June 2014
- 22/09/14 : Media Release Small Bone Innovations
- 29/08/14 : Appendix 4E Preliminary Final Report 30 June 2014
- 02/04/14 : Synthetic Bone Substitute Licence from The University of Sydney
- 28/02/14 : Half Yearly Report and Accounts
- 21/02/14: Expiry of Options
- 30/10/13 : Results of 2013 Annual General Meeting
- 27/09/13 : Notice of Annual General Meeting/Proxy Form
- 18/09/13 : Annual Report – 30 June 2013
- 30/08/13 : Appendix 4E Preliminary Final Report/Annual Report – 30 June 2013
- 09/08/13 : Cancellation of Options
- 07/08/13: ASX Media Release – Signs Transitional Services Agreement with Orthofix
- 01/05/13 : Appoints New Chief Executive Officer
- 02/04/13 : Non-Renounceable Rights Issue – Notice of Under Subscriptions
- 11/03/13 : Notice to Ineligible Shareholders – Rights Issue
- 11/03/13 : Notice of Despatch – Rights Issue
- 26/02/13: Rights Issue Notice to Shareholders
- 26/02/13: Rights Issue Notice to Optionholders
- 25/02/13: Rights Issue – Revised Timetable
- 25/02/13: Rights Issue – Offer Document – Revised Timetable
- 25/02/13: Entitlement Acceptance Form – Revised Timetable
- 25/02/13: Appendix 3B-Revised Rights Timetable
- 25/02/13: Cleansing Statement-Rights Issue – Revised Timetable
- 22/02/13: Cleansing Statement – Rights Issue
- 22/02/13: Rights Issue – Entitlement and Acceptance Form
- 22/02/13: Placement Cleansing Statement
- 22/02/13: Half Yearly Reports and Accounts
- 22/02/13: Non-Renounceable Pro Rata Rights Issue to raise $1.5m
- 22/02/13: Appendix 3B – Rights Issue
- 22/02/13: Rights Issue Offer Document
- 20/02/13: Substantial Shareholder Notice Form 603
- 19/02/13 : Placement & Rights Issue
- 19/02/13 : New Issue Announcement
- 14/12/12: ASDM 2012 Shareholder Update
- 29/11/12 : Results of 2012 Annual General Meeting
- 23/10/12 : Appendix 3B New Issue Announcement
- 28/09/12 : Annual Report – 30 June 2012
- 31/08/12 : Preliminary Final Results
- 30/07/12: Video – Achieving medical breakthroughs matters to Hala Zreiqat
- 17/07/12 : ASX Market Announcements
- 26/03/12 : Executive Management Changes
- 27/02/12 : ASDM – Interim Report
- 16/02/12 : ASDM Expands Product Portfolio
- 23/11/11 : Appoints Director
- 23/11/11 : Initial Director’s Interest Notice
- 25/10/11 : Results of Annual General Meeting
- 25/10/11 : Chairman’s Address to Shareholders
- 25/10/11 : CEO’s AGM Address
- 26/09/11 : Annual Report 2011
- 23/09/11 : Notice of Annual General Meeting and Shareholder Voting Form
- 20/09/11 : ASDM Enters The $250M Australian Spinal Market With Global Brand
- 31/08/11 : Appendix 4E Preliminary Final Report
- 31/08/11 : 2011 Full Year Results
- 16/05/11 : Shareholder Newsletter – May 2011
- 04/03/11 : Signs Commercial Arrangement with Surgeon Group
- 02/03/11 : Interim Report – 31 December 2010
- 02/03/11 : Results for the half year ended 31 December 2010
- 16/02/11 : Completes Strategic Review
- 14/02/11 : Appoints National Sales Manager
- 06/12/10 : Positive Interim Results For Clinical Trial
- 15/11/10 : Amended Constitution
- 15/11/10 : Appendix 3Z Final Director’s Interest Notice
- 05/11/10 : 2010 AGM – Chairman’s Address
- 05/11/10 : 2010 AGM – CEO Presentation
- 04/11/10: New Distribution Agreement Broadens Market
- 20/10/10 : New Distribution Agreement For Substantial Growth In Sales And Profit
- 11/10/10 : Signs Distribution Agreement With Arthrosurface Inc
- 07/10/10 : Appendix 3Y Change of Director’s Interest Notice
- 01/10/10 : 2010 Proxy Form
- 01/10/10 : 2010 AGM Notice
- 27/09/10 : Annual Report 2010
- 20/09/10 : Major New Revenue Opportunities
- 15/09/10 : Appendix 3X Initial Director’s Interest Notice
- 31/08/10 : Appendix 4E Preliminary Final Report
- 06/07/10 : ASDM Signs Landmark PAD Licensing Deal
- 08/06/10 : Broadcast – First PAD trial patient discharged
- 08/06/10 : Shareholders Newsletter June 2010
- 19/05/10 : Establishes direct presence in Europe
- 09/04/10 : ASX Media Release – Major Trial For World-First Major Limb Saving
- 26/03/10 : Appendix 3B New Issue Announcement
- 22/03/10 : Presentation of PAD Pilot Trial Results at Association of International Vascular Surgeons Conference
- 01/03/10 : Appendix 3Y Change of Director’s Interest Notice
- 01/03/10 : Appendix 3X Initial Director’s Interest Notice
- 01/03/10 : Appointment of Director
- 01/03/10 : FDA Registration Posterior Stabilised Knee
- 22/02/10: Half year press release
- 22/02/10: Appendix 4D
- 7/12/09 : New Issue Announcement Appendix 3B
- 2/12/09 : First Sales in Continental Europe Class III CE Mark
- 26/11/09 : 2009 AGM Chairmans Report
- 26/11/09 : 2009 AGM CEO Report
- 26/11/09 : 2009 AGM Results of Meeting
- 29/10/09 : Surgical Device sold to US multi-national
- 29/9/09 : Annual Report 2009
- 1/9/09 : Cancellation of Options
- 26/8/09 : 2009 Full Year Results
- 26/08/09 : Appendix 4E Preliminary Final Report
- 21/7/09 : Newsletter
- 26/6/09 : US Distributor Announcement
- 20/11/08 : Change of Director’s Interest Notice
- 20/11/08 : Appendix 3B
- 12/11/08 : Results of Meeting
- 12/11/08 : Chairman’s Address to Shareholders
- 29/10/08 : Business Update
- 10/10/08 : Proxy Form
- 10/10/08 : Notice of Annual General Meeting
- 09/10/08 : Change of Director’s Interest Notice
- 01/10/08 : Shareholder Business Update
- 30/09/08 : Annual Report 2008
- 03/09/08 : Change of Director’s Interest Notice
- 28/08/08 : Change of Director’s Interest Notice
- 20/08/08 : Appendix 4E Preliminary Final Report
- 20/08/08 : 2008 Full Year Results
- 28/07/08 : PLD Portland Denies Hip Cup Patent Infringement
- 24/07/08 : US Hip Cup Patent
- 21/07/08 : Investor update
- 21/05/08 : US Patent on Pivotal Hip Prosthesis Design
- 21/04/08 : April 08 Investor Update
- 03/04/08 : PAD on ABC’s Catalyst Program
- 06/03/08 : Licensing of Polishing Technology
- 26/02/08 : Feb 08 CEO Roadshow Presentation
- 22/02/08 : ASX Announcement December 2007 Half Year Results
- 22/02/08 : December 2007 Half Year Results
- 31/01/08 : 10th Patient Treated with PAD
- 20/12/07 : Results of 2007 AGM
- 20/12/07 : Chairman & CEO AGM Addresses
- 14/12/07 : Notice of Initial Substantial Holder
- 11/12/07 : Notice of Initial Substantial Holder
- 11/12/07 : MD presentation at Informa National Prostheses Congress Syd
- 7/12/07 : Change of Director`s Interest Notice
- 7/12/07 : Initial Director`s Interest Notice
- 6/12/07 : AMT Lists on ASX – Interview with MD Dr Greg Roger
- 6/12/07 : AGM Proxy Form
- 6/12/07 : Notce of Annual General Meeting
- 30/11/07 : Confirmation of Employee Share Issue
- 30/11/07 : Voluntary Escrow
- 30/11/07 : Distribution Schedule
- 30/11/07 : ASX Circular: Commencement of Official Quotation
- 30/11/07 : 2006 Annual Report
- 30/11/07 : Corporate Governance Statement
- 30/11/07 : Employee Option Terms
- 30/11/07 : Admission to Official List
- 30/11/07 : Top 20 Shareholders
- 30/11/07 : Constitution
- 30/11/07 : Appendix 1A: ASX Listing Application and Agreement
- 30/11/07 : 2005 Annual Report
- 30/11/07 : Pro Forma Balance Sheet
- 30/11/07 : Escrowed Securities
- 30/11/07 : Option Terms
- 30/11/07 : Pre Quotation Disclosure
- 30/11/07 : 2007 Annual Report
- 30/11/07 : Employee Share Option Plan
- 14/11/07 : Prospectus